Five-year clinical outcomes after percutaneous edge-to-edge mitral valve repair: Insights from the multicenter GRASP-IT registry

ConclusionsAt 5-year follow-up after Mitraclip nearly half of patients died and almost two-third died or were admitted for HF. MR recurrence, ischaemic etiology, high comorbidity burden (i.e. EuroSCORE II> 5%, COPD), and advanced cardiomyopathy (i.e. LVEF<30%, prior HF admission, creatinine>1.5 mg/dL) significantly increase the relative risk of 5-year clinical events.
Source: American Heart Journal - Category: Cardiology Source Type: research